Innovator IBD 50 ETF (FFTY)

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.

The chart shows the growth of an initial investment of $10,000 in Innovator IBD 50 ETF, comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.

Innovator IBD 50 ETF (FFTY) has returned -4.02% so far this year and 25.53% over the past 12 months. Over the last ten years, FFTY has returned 5.25% per year, falling short of the S&P 500 Index benchmark, which averaged 12.16% annually.

Based on dividend-adjusted daily data since Apr 9, 2015, FFTY's average daily return is +0.03%, while the average monthly return is +0.51%. At this rate, your investment would double in approximately 11.4 years.

Historically, 58% of months were positive and 42% were negative. The best month was Nov 2024 with a return of +18.3%, while the worst month was Oct 2018 at -18.6%. The longest winning streak lasted 7 consecutive months, and the longest losing streak was 4 months.

On a daily basis, FFTY closed higher 55% of trading days. The best single day was Mar 24, 2020 with a return of +8.5%, while the worst single day was Mar 16, 2020 at -12.8%.

Innovator IBD 50 ETF has an annualized alpha of -6.76%, beta of 1.15, and R² of 0.59 versus S&P 500 Index. Calculated based on daily prices since April 10, 2015.

• This ETF participated in 136.81% of S&P 500 Index downside but only 104.22% of its upside — more exposed to losses than it benefited from rallies.
• This ETF had an annualized alpha of -6.76% versus S&P 500 Index — delivering less than market exposure alone would predict.
• With beta of 1.15 and R² of 0.59, this ETF moves broadly in line with S&P 500 Index — much of its variation is explained by market exposure rather than independent behavior.

FFTY has an expense ratio of 0.80%, placing it in the medium range.

FFTY ranks 37 for risk / return — below 37% of ETFs on our site. The returns aren't fully compensating for the risk involved. This isn't necessarily a dealbreaker, but factor it into your decision — especially if you're risk-averse.

The table below present risk-adjusted performance metrics for Innovator IBD 50 ETF (FFTY) and compare them to a chosen benchmark (S&P 500 Index).

Innovator IBD 50 ETF provided a 1.40% dividend yield over the last twelve months, with an annual payout of $0.47 per share. The fund has been increasing its distributions for 2 consecutive years.

The table displays the monthly dividend distributions for Innovator IBD 50 ETF. The dividends shown in the table have been adjusted to account for any splits that may have occurred.

The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.

The table below displays the maximum drawdowns of the Innovator IBD 50 ETF. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the Innovator IBD 50 ETF was 59.46%, occurring on Oct 27, 2023. The portfolio has not yet recovered.

The current Innovator IBD 50 ETF drawdown is 32.35%.

The chart below shows the rolling one-month volatility.